Who are the invited speakers?

Isabel Barragan 

Ph.D. Scientist and Group Leader of Translational Research in Cancer Immunotherapy and Epigenetics (IBIMA-BIONAND Platform) and 
Pharmacoepigenetics

Dpt of Physiology and Pharmacology
Karolinska Institutet, Stockholm, Sweden

Epitranscriptomic regulation of response to Immune Checkpoint Blockade 

Elena Bochenkova

MD and Research Scientist, MD at Department of Biochemistry, University of Zurich, Switzerland
Targeting METTL3 as a novel therapeutic strategy for acute myeloid leukemia

Sandra Blanco 

Research Scientist, CSIC,  Head of Epitranscriptomics and Cancer Lab
Salamanca, Spain
Targeting RNA methylases in cancer

Luca Cozzuto

Senior Bioinformatician
at the Bionformatics Technology Unit, Barcelona, Spain
MasterOfPores3: a suite of pipelines for nanopore sequencing data

Pierre-Antoine Defossez 

Group leader, CNRS

Research Scientist, Epigenetics and cell fate Lab, Paris, France
Dynamics and interpretation of DNA methylation in mammals

Maite Huarte

Director of DNA and RNA Medicine Division and Head of the Noncoding RNA and Cancer Genome Lab at CIMA, Univ. of Navarra,  Pamplona, Spain
Noncoding RNA in preserving genomic stability


Rory Johnson

Associate Professor
School of Biology and Environmental Science, University College of Dublin, Ireland
Non-protein coding RNA drivers of tumorigenesis

Eleonora Leucci

Professor at KU Leuven, Belgium
Adaptation to anticancer therapy: to be or not to be coding that’s the question

Marie Lopez

Research Scientist, Institut des biomolécules Max Mousseron (IBMM), CNRS-Univ. Montpellier-ENSCM UMR5247CNRS, Montpellier, France
Multifunctional chemical compounds to target epigenetic mechanisms in cancer

Mathieu Lupien

Senior scientist
Princess Margaret Cancer Centre
University Health Network
Professor University of Toronto, Canada
Decoding intra-tumour heterogeneity from chromatin variants

Antonin Morillon

Research scientist, Group leader at Institut Curie, CNRS, Sorbonne University, PSL, UMR3244, Paris
Dark genome and cancer


Francesco Nicassio

Center Coordinator - Senior Researcher Tenured
Center for Genomic Science of IIT@SEMM (CGS), Milan, Italy
Cellular and molecular heterogeneity in human cancer


Charlotte Proudhon

INSERM Investigator
Group leader, IRSET
Research Institute for Environmental and Occupational Health, Rennes, France
Non-invasive multi-cancer diagnosis targeting LINE-1 retrotransposons reactivation

Céline Vallot

Research Scientist, CNRS, Head of the Dynamics of Epigenetic Plasticity group at Institut Curie, Paris, France
Mechanisms of cell plasticity in triple negative breast cancer